These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1684975

  • 1. Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.
    McCann UD, Ricaurte GA.
    J Clin Psychopharmacol; 1991 Oct; 11(5):302-5. PubMed ID: 1684975
    [Abstract] [Full Text] [Related]

  • 2. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G, Bailly D, Boss V, Thomas P, Lestavel P, Goudemand M.
    Encephale; 2001 Oct; 27(2):198-202. PubMed ID: 11407274
    [Abstract] [Full Text] [Related]

  • 3. Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    McCann UD, Ricaurte GA.
    J Clin Psychopharmacol; 1993 Jun; 13(3):214-7. PubMed ID: 8102623
    [Abstract] [Full Text] [Related]

  • 4. Recreational ecstasy use and depression.
    Guillot C, Greenway D.
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [Abstract] [Full Text] [Related]

  • 5. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 6. Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.
    Soar K, Parrott AC, Fox HC.
    Psychol Rep; 2004 Aug; 95(1):192-6. PubMed ID: 15460375
    [Abstract] [Full Text] [Related]

  • 7. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ, McGregor IS, Hunt GE, Cornish JL.
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [Abstract] [Full Text] [Related]

  • 9. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS.
    Biol Psychiatry; 1996 May 01; 39(9):819-20. PubMed ID: 8731525
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Executive function in abstinent MDMA ('ecstasy') users.
    Zakzanis KK, Young DA.
    Med Sci Monit; 2001 May 01; 7(6):1292-8. PubMed ID: 11687745
    [Abstract] [Full Text] [Related]

  • 14. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 15. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG, Sorrentino R, Lukas SE, Price BH.
    Harv Rev Psychiatry; 2002 Jun 01; 10(4):212-20. PubMed ID: 12119307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged exercise.
    Seymour HR, Gilman D, Quin JD.
    Diabet Med; 1996 Oct 01; 13(10):908-9. PubMed ID: 8911787
    [Abstract] [Full Text] [Related]

  • 19. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
    Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.
    J Psychopharmacol; 2006 May 01; 20(3):389-99. PubMed ID: 16574713
    [Abstract] [Full Text] [Related]

  • 20. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
    Peroutka SJ, Newman H, Harris H.
    Neuropsychopharmacology; 1988 Dec 01; 1(4):273-7. PubMed ID: 2908020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.